| Literature DB >> 17974726 |
Patrick Jean-Philippe1, Abigail Freedman, Mary Wu Chang, Sharon P Steinberg, Anne A Gershon, Philip S LaRussa, William Borkowsky.
Abstract
In March 1995, the US Food and Drug Administration approved a live attenuated varicella vaccine for use in healthy children 12 months to 12 years old. We report here an 18-month-old girl with cell-mediated immunodeficiency who developed a severe vaccine-associated rash and clinical evidence of vaccine-associated pneumonia 1 month after inadvertent receipt of varicella vaccine.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17974726 DOI: 10.1542/peds.2004-1681
Source DB: PubMed Journal: Pediatrics ISSN: 0031-4005 Impact factor: 7.124